Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr-Jun;104(2):368504211029435.
doi: 10.1177/00368504211029435.

Health professional's exposure, attitude, and acceptance of drug promotion by industry representatives: A cross-sectional study in Ethiopia

Dawit Kumilachew Yimenu  1 , Chilot Abiyu Demeke  1 , Asmamaw Emagn Kasahun  1 , Ebrahim Abdela Siraj  2 , Adane Yehualaw Wendalem  3 , Zegaye Agmassie Bazezew  4 , Berhanemeskel Weldegerima Atsbeha  1 , Abebe Basazn Mekuria  5
Affiliations

Health professional's exposure, attitude, and acceptance of drug promotion by industry representatives: A cross-sectional study in Ethiopia

Dawit Kumilachew Yimenu et al. Sci Prog. 2021 Apr-Jun.

Abstract

Interactions between pharmaceutical companies and health care providers have long been an area of interest from ethical as well as scientific grounds. The information provided by those companies must be scientifically accurate and fair. The current study aimed to investigate the exposure, attitude, and training background of medical doctors and pharmacy professionals regarding drug promotional activities, and assess their acceptance of promotional gifts provided by pharmaceutical sales representatives. A cross-sectional study was conducted on medical doctors and pharmacy professionals working at Bahir Dar and Gondar cities, Amhara regional state, Ethiopia. Data were collected using a self-administered structured questionnaire and Statistical Package for Social Science (SPSS) version 26 was used for analysis. A Chi-square test was computed to investigate the presence of an association between the dependent and independent variables. A p-value of less than 0.05 was considered to declare significance at a 95% Confidence Interval (CI). A total of 105 health professionals, 81 pharmacy professionals, and 24 medical doctors have participated in the study. Above two-thirds of the respondents (69.5%) agreed that most talks sponsored by drug companies were helpful and educational. On the other hand, 39% of the respondents agreed and 47.6% disagreed that receiving gifts from pharmaceutical representatives will increase the chance that they will eventually sell or recommend the drug company's products. The majority of the study participants (81%) preferred drug samples and stationery as appropriate gifts by pharmaceutical sales representatives. Significant gaps were found regarding the training of health professionals about the ethics of drug marketing and how to deal with pharmaceutical representatives. Policies aiming at restricting health care provider's contacts with pharmaceutical companies during residency training along with incorporating gift restriction policies could bring significant improvements.

Keywords: Promotion; doctors; drug; pharmacists; pharmacy professionals.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Study participants exposure to pharmaceutical promotion.
Figure 2.
Figure 2.
Participants exposure to pharmaceutical promotion classified by type of profession.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Francer J, Izquierdo JZ, Music T, et al.. Ethical pharmaceutical promotion and communications worldwide: codes and regulations. Philos Ethics Humanit Med 2014; 9(1): 7. - PMC - PubMed
    1. Mondiale de la Santé O. WHO ethical criteria for medicinal drug promotion, https://apps.who.int/iris/handle/10665/171783 (1993, accessed 14 February 2021).
    1. Zaki NM. Pharmacists’ and physicians’ perception and exposure to drug promotion: a Saudi study. Saudi Pharm J 2014; 22(6): 528–536. - PMC - PubMed
    1. Schwartz LM, Woloshin S. Medical marketing in the United States, 1997–2016. JAMA 2019; 321(1): 80–96. - PubMed
    1. Mackey TK, Cuomo RE, Liang BA. The rise of digital direct-to-consumer advertising? Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications. BMC Health Serv Res 2015; 15(1): 236. - PMC - PubMed

Substances

LinkOut - more resources